Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy

Ophthalmologica

Volumn 227, Issue 4, 2012, Pages 190-196

  Mosci, Carlo ^a   Lanza, Francesco Baldo ^a   Barla, Annalisa ^b   Mosci, Sofia ^b   Hérault, Joël ^e   Anselmi, Luca ^c   Truini, Mauro ^d  

^a GALLIERA HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c ASL 3   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Choroidal melanoma; Melanoma; Ocular tumours; Radiation oncology; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHOROID MELANOMA; ENUCLEATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PROTON THERAPY; TREATMENT OUTCOME; UVEA MELANOMA; VISUAL ACUITY;

AGED; CAUSE OF DEATH; CHOROID NEOPLASMS; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROTONS; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84860432600     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000334401     Document Type: Article

References (22)

1. Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E, EUROCARE Working Group: Incidence of uveal melanoma in Europe. Ophthalmology 2007; 114: 2309-2315.
2. Zimmerman LE, McLean IW, Foster WD: Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells? Br J Ophthalmol 1978; 62: 420-425.
3. Collaborative Ocular Melanoma Study Group: The COMS randomized trial of iodine-125 brachytherapy for choroidal melanoma. V. Twelve-year mortality rates and prognostic factors. COMS Report No. 28. Arch Ophthalmol 2006; 124: 1684-1693.
4. Gragoudas ES, Goitein M, Verhey L, Munzenreider J, Suit HD, Koehler A: Proton beam irradiation: an alternative to enucleation for intraocular melanomas. Ophthalmology 1980; 87: 571-581.
5. Augsburger JJ, Corrêa ZM, Trichopoulos N: An alternative hypothesis for observed mortality rates due to metastasis after treatment of choroidal melanomas of different sizes. Trans Am Ophthalmol Soc 2007; 105: 54-59.
6. Collaborative Ocular Melanoma Study Group: Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma. Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol 2005; 123: 1639-1643.
7. Egger E, Zografos L, Schalenbourg A, Beati D, Böhringer T, Chamot L, Goitein G: Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 2003; 55: 867-880.
8. Edge SD, Byrd DR, Carducci MA, Compton CC, Fritz AG, Greene FL: AJCC Cancer Staging Manual, ed 7. New York, Springer, 2009.
9. Kaplan E, Meier P: Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
10. Cox DR: Regression models and life-tables. J R Stat Soc B 1972; 34: 187-220.
11. Shammas HF, Blodi FC: Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977; 95: 63-69.
12. Damato B, Coupland SE: A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond) 2009; 23: 2152-2160.
13. Eide N, Walaas L: Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease. Acta Ophthalmol 2009; 87: 588-601.
14. Collaborative Ocular Melanoma Study Group: The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma. IV. Ten-year mortality findings and prognostic factors. COMS Report No. 24. Am J Ophthalmol 2004; 138: 936-951.
15. Shields CL, Naseripour M, Cater J, Shields JA, Demirci H, Youseff A, Freire J: Plaque radiotherapy for large posterior uveal melanomas ( ≥ 8 mm thick) in 354 consecutive patients. Ophthalmology 2002; 109: 1838-1849.
16. Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivelä T: Iodine brachytherapy as an alternative to enucleation for large uveal melanomas. Ophthalmology 2003; 110: 2223-2234.
17. Kaiserman N, Kaiserman I, Hendler K, Frenkel S, Pe'er J: Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas. Br J Ophthalmol 2009; 93: 1167-1171.
18. Damato B, Foulds WS: Indications for transscleral local resection of uveal melanoma. Br J Ophthalmol 1996; 80: 1029-1030.
19. Puusaari I, Damato B, Kivelä T: Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height. Graefes Arch Clin Exp Ophthalmol 2007; 245: 522-533.
20. Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM: Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 2002; 120: 1665-1671.
21. Mosci C, Mosci S, Barla A, Squarcia S, Chauvel P, Iborra N: Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France. Eur J Ophthalmol 2009; 19: 654-660.
22. Conway RM, Poothullil AM, Daftari IK, Weinberg V, Chung JE, O'Brien JM: Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy. Arch Ophthalmol 2006; 124: 838-843.